Table 2c Laboratory parameters of patients with chronic liver diseases

From: The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis

Laboratory parameter

All patients n=360/392

Test cohort n=275/307

Validation cohort n=85/85

P-value

AST (U/ml) median (IQR)

42.5 (29.0;68.0)

39.0 (27.0;64.0)

53.0 (34.0;75.0)

0.004

ALT (U/ml); median (IQR)

52.0 (33.0;93.5)

50.5 (31.0;91.0)

59.0 (40.0;115.5)

0.057

GGT (U/ml); median (IQR)

80.0 (38.0;186.0)

80.0 (37.0;208.0)

84.0 (45.5;166.0)

0.817

Albumin (mg/dl); median (IQR)

44.0 (41.0; 46.4)

43.5 (39.9;46.3)

45.0 (43.0;47.0)

0.016

Total bilirubin (mg/dl); median (IQR)

0.7 (0.5;1.0)

0.7 (0.5;1.1)

0.64 (0.46;0.86)

0.033

Platelet count (G/L); median (IQR)

221.5 (180.0;276.8)

224.0 (181.0;285.0)

212.0 (172.0;250.5)

0.106

MELD score; median (IQR)

7.2 (6.4;8.5)

7.5 (6.4;8.5)

6.9 (6.4;7.8)

0.049

Back to article page